PP_1170x120_10-25-21

JAMA Network Open

State laws aimed at drug price transparency won’t help, study says

State laws aimed at drug price transparency won’t help, study says

LOS ANGELES — Less than 5% of state drug pricing laws passed between 2015 and 2018 will provide new information about pricing within the pharmaceutical distribution system. The rest of the laws passed either do not focus on transparency at all, or mandate reporting of information that is already publicly available, according to a new